Group Hypnosis for Irritable Bowel Syndrome
IBS
GUT-FOCUSED GROUP HYPNOSIS FOR TREATMENT OF IRRITABLE BOWEL SYNDROME - A RANDOMISED CONTROLLED TRIAL
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
This randomised controlled trial (RCT) aimed at assessing the efficacy of hypnotherapy in group sessions (GHT) with a 12-months follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2008
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 9, 2010
CompletedFirst Posted
Study publicly available on registry
August 10, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedDecember 13, 2011
December 1, 2011
2.4 years
August 9, 2010
December 11, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Irritable Bowel Syndrome - Impact Scale, IBS-IS
the IBS-Impact-Scale (IBS-IS). The IBS-IS is a disease-specific documentation of the impact of IBS on patients' lives and was developed and validated for use in clinical trials
May 2008-September 2010
Secondary Outcomes (1)
Short-Form 36 (SF-36)
May 2008-September 2010
Study Arms (2)
Standard Medical Therapy (SMT)
NO INTERVENTIONstandard medical treatment (care as usual) with supportive talks
Gut focused hypnotherapy
ACTIVE COMPARATORweekly sessions of gut focused hypnotherapy in groups (10 sessions within 12 weeks)
Interventions
weekly session (45 min) of gut focused hypnotherapy (10 sessions within 12 weeks)
Eligibility Criteria
You may qualify if:
- Patients with IBS, fulfilling Rome III criteria, and aged between 18 and 70, The time for patients to reach the hospital should not to be longer than one hour
You may not qualify if:
- pregnancy, bowel surgery, mental retardation, insufficient knowledge of German, a concomitant severe organic and/or psychiatric disease, recently indicated treatment with anti-depressants.-
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gabriele Moser, ao. Prof.
Medical University of Vienna
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- ao.Univ.Prof.Dr.med.
Study Record Dates
First Submitted
August 9, 2010
First Posted
August 10, 2010
Study Start
April 1, 2008
Primary Completion
September 1, 2010
Study Completion
July 1, 2011
Last Updated
December 13, 2011
Record last verified: 2011-12